With advancements in modern medicine, the overall rate of new breast cancer cases has declined a total of 43 percent since 1989, says Breastcancer.org. That is a promising number. However, it can ...

New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...

The FDA put a black box warning on estrogen products for hormone therapy in 2003, and it’s stayed there ever since. And women ...

Scientists at The Wistar Institute have solved a longstanding puzzle in ovarian cancer treatment: why anti-estrogen therapy ...

While it has long been recognized that drugs that block the cancer-promoting activity of estrogen reduce risk of developing new breast cancers, a new computer modeling study has shown that these ...

A new study from researchers at Baylor College of Medicine brings hope for a more personalized approach to treat estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer.

CHICAGO (Reuters) - Taking the breast cancer pill Femara can significantly reduce the chances that a woman's cancer will return, even long after she has stopped taking the estrogen blocker tamoxifen, ...

Dear Dr. Roach: You recommended estrogen cream for UTI problems. I had breast cancer, and it was estrogen-positive. I was on tamoxifen for six years; it is an estrogen blocker. As a result, I am ...